Publications by authors named "Alan Mitchell"

Claim this Profile
P
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy.
Chad Pickering, Paul Aiyetan, Gege Xu, Alan Mitchell, Rachel Rice

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal inference for longitudinal data based on historical controls.
Jeen Liu, Jane Zhang, Alan Mitchell, Mindy Fang, Lu Tian

J Biopharm Stat· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased bleeding and thrombosis in myeloproliferative neoplasms mediated through altered expression of inherited platelet disorder genes.
Alan Mitchell, Mattia Frontini, Serajul Islam, Suthesh Sivapalaratnam, Anandi Krishnan

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
Norah E Palmateer, David J Goldberg, Alison Munro, Avril Taylor, Alan Yeung, Alan Mitchell

Addiction· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants.
Yogesh S Jethava, Alan Mitchell, Joshua Epstein, Maurizio Zangari, Shmuel Yaccoby

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Total Lesion Glycolysis by F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.
James E McDonald, Marcus M Kessler, Michael W Gardner, Amy F Buros, James A Ntambi, Alan Mitchell

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Valerie W Rusch, Ritu Gill, Alan Mitchell, David Naidich, David C Rice

Ann Thorac Surg· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.
Ritu R Gill, David P Naidich, Alan Mitchell, Michelle Ginsberg, Jeremy Erasmus

J Thorac Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
Paul T Nghiem, Shailender Bhatia, Evan J Lipson, Ragini R Kudchadkar, Natalie J Miller, Alan Mitchell

N Engl J Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the Letter to the Editor by Hendriks et al.
Wilfried Ernst Erich Eberhardt, Alan Mitchell, Ramon Rami-Porta

J Thorac Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Alan Mitchell

J Thorac Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Wilfried E E Eberhardt, Alan Mitchell, John Crowley, Haruhiko Kondo, Young Tae Kim

J Thorac Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curing myeloma at last: defining criteria and providing the evidence.
Bart Barlogie, Alan Mitchell, Frits van Rhee, Joshua Epstein, Gareth J Morgan

Blood· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early phase trial design for assessing several dose levels for toxicity and efficacy for targeted agents.
Antje Hoering, Alan Mitchell, Michael LeBlanc, John Crowley

Clin Trials· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma.
Xenofon Papanikolaou, Jackie Szymonifka, Adam Rosenthal, Christoph J Heuck, Alan Mitchell

Haematologica· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3.
Saad Z Usmani, Alan Mitchell, Sarah Waheed, John Crowley, Antje Hoering

Blood· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer. An analysis of the staging project database of the International Association for the Study of Lung Cancer.
David Ball, Alan Mitchell, Dori Giroux, Ramon Rami-Porta,

J Thorac Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.
Sarah Waheed, Alan Mitchell, Saad Usmani, Joshua Epstein, Shmuel Yaccoby

Haematologica· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents.
Saad Z Usmani, Christoph Heuck, Alan Mitchell, Jackie Szymonifka, Bijay Nair

Haematologica· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting tree responses to thinning and fertilization using tree-ring stable isotopes.
J Renée Brooks, Alan K Mitchell

New Phytol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the other 90%: phytoplankton responses to enhanced nutrient availability in the Great Barrier Reef Lagoon.
Miles Furnas, Alan Mitchell, Michele Skuza, Jon Brodie

Mar Pollut Bull· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
Sharon J Hutchinson, Sarah Wadd, Avril Taylor, Sheila M Bird, Alan Mitchell

Vaccine· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis